Business Context and Reporting Period
This Form 8-K is a current report filed by India Globalization Capital, Inc. (IGC Pharma, Inc.) on December 15, 2017. The filing addresses corporate governance actions regarding the adjournment of shareholder voting for specific proposals from the Annual Meeting of Shareholders originally scheduled for October 5, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.
Material Changes
The primary material change reported is the adjournment of voting for two specific shareholder proposals:
- Proposal Three: Approval to grant 1,900,000 shares of common stock to current and new employees, advisors, directors, and consultants based on board-set metrics.
- Proposal Four: Approval to issue up to 2,000,000 shares of common stock to Bricoleur Partners, L.P.
Voting on these proposals was adjourned to December 29, 2017, to allow stockholders additional time to vote. Proxies previously submitted remain valid unless revoked.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary contingency noted is the requirement for stockholders to vote by December 29, 2017, at 11:59 p.m. Eastern Standard Time via internet, telephone, or mail to ensure their votes are counted on the adjourned proposals.
Investor Verification Checklist
- Verify the status of the adjourned Annual Meeting scheduled for December 29, 2017.
- Confirm the potential dilution impact of the proposed issuance of 1,900,000 shares to employees and 2,000,000 shares to Bricoleur Partners, L.P.
- Review the attached Press Release (Exhibit 99.1) for additional details on the rationale for the adjournment.
- Check subsequent filings to determine if the proposals were approved at the adjourned meeting.